scholarly article | Q13442814 |
P356 | DOI | 10.1001/JAMA.2010.1205 |
P698 | PubMed publication ID | 20736474 |
P50 | author | Bruce M. Psaty | Q30429993 |
David S Siscovick | Q86839898 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | bias | Q742736 |
P304 | page(s) | 897-898 | |
P577 | publication date | 2010-08-01 | |
P1433 | published in | The Journal of the American Medical Association | Q1470970 |
P1476 | title | Minimizing bias due to confounding by indication in comparative effectiveness research: the importance of restriction. | |
P478 | volume | 304 |
Q51643878 | A new prognostic index for overall survival in malignant pleural mesothelioma: the rPHS (regimen, PS, histology or stage) index. |
Q30887169 | A practical guide for using registry data to inform decisions about the cost effectiveness of new cancer drugs: lessons learned from the PHAROS registry |
Q35883274 | A propensity-matched study of the comparative effectiveness of angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors in heart failure patients age ≥ 65 years |
Q38387733 | Active-comparator design and new-user design in observational studies |
Q60044793 | Acute kidney injury in postoperative shock: is hyperoncotic albumin administration an unrecognized resuscitation risk factor? |
Q39256176 | Adjunctive traditional Chinese medicine therapy improves survival in patients with advanced breast cancer: a population-based study. |
Q30661964 | Adrenaline (epinephrine) dosing period and survival after in-hospital cardiac arrest: a retrospective review of prospectively collected data |
Q30696956 | An analytic framework for aligning observational and randomized trial data: Application to postmenopausal hormone therapy and coronary heart disease |
Q36851454 | Angiotensin-converting enzyme inhibitors and outcomes in heart failure and preserved ejection fraction |
Q37626595 | Antihypertensive medications and risk of death and hospitalizations in US hemodialysis patients: Evidence from a cohort study to inform hypertension treatment practices. |
Q43430988 | Assessing the comparative effectiveness of newly marketed medications: methodological challenges and implications for drug development. |
Q36072330 | Clinical and economic outcomes of thyroid surgery in elderly patients: a systematic review |
Q35680854 | Clopidogrel use and early outcomes among older patients receiving a drug-eluting coronary artery stent |
Q40280177 | Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries in Preventing Postinfluenza Deaths During 2012-2013 and 2013-2014. |
Q33997802 | Comparative effectiveness of 2 β-blockers in hypertensive patients |
Q41299360 | Comparative effectiveness of beta-lactams versus vancomycin for treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections among 122 hospitals |
Q38969469 | Comparative effectiveness of mycophenolate mofetil for the treatment of childhood-onset proliferative lupus nephritis |
Q28732445 | Comparative effectiveness research in lung diseases and sleep disorders: recommendations from the National Heart, Lung, and Blood Institute workshop |
Q45937309 | Comparing methods to address bias in observational data: statin use and cardiovascular events in a US cohort. |
Q36947797 | Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort stu |
Q34647118 | Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study |
Q35846647 | Conducting comparative effectiveness research on medications: the views of a practicing epidemiologist from the other Washington |
Q36008497 | Confronting "confounding by health system use" in Medicare Part D: comparative effectiveness of propensity score approaches to confounding adjustment |
Q36573102 | Disease-modifying antirheumatic drug use and the risk of incident hyperlipidemia in patients with early rheumatoid arthritis: a retrospective cohort study |
Q35658906 | Diuretic use, increased serum urate levels, and risk of incident gout in a population-based study of adults with hypertension: the Atherosclerosis Risk in Communities cohort study |
Q33730879 | Effect of β-blockers on cardiac and pulmonary events and death in older adults with cardiovascular disease and chronic obstructive pulmonary disease |
Q34020625 | Etomidate, adrenal function, and mortality in critically ill patients |
Q38171873 | Evaluating methodological assumptions in comparative effectiveness research: overcoming pitfalls |
Q35136444 | Evaluation of low-dose aspirin for primary prevention of ischemic stroke among patients with diabetes: a retrospective cohort study |
Q36455050 | Exposure to oral bisphosphonates and risk of cancer |
Q36925442 | External adjustment sensitivity analysis for unmeasured confounding: an application to coronary stent outcomes, Pennsylvania 2004-2008. |
Q35876254 | Fracture risk in men with prostate cancer: a population-based study. |
Q35991921 | Fracture risk in women with breast cancer: a population-based study. |
Q55299717 | Impact of bronchiectasis on outcomes of hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease: A propensity matched analysis. |
Q37594735 | Mortality after prostate cancer treatment with radical prostatectomy, external-beam radiation therapy, or brachytherapy in men without comorbidity |
Q28482730 | Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients |
Q47548156 | New statin use and left ventricular structure: Estimating long-term associations in the Multi-Ethnic Study of Atherosclerosis (MESA). |
Q28703603 | Observational comparative effectiveness studies of drug therapies: high-quality answers or important clinical questions?: comment on "Comparative effectiveness of 2 β-blockers in hypertensive patients" |
Q30538243 | Observational data for comparative effectiveness research: an emulation of randomised trials of statins and primary prevention of coronary heart disease |
Q97568852 | Oral anticoagulants and risk of acute liver injury in patients with nonvalvular atrial fibrillation: a propensity-weighted nationwide cohort study |
Q24595632 | Oral contraceptives and the risk of gallbladder disease: a comparative safety study |
Q35140167 | Propensity score matching: a conceptual review for radiology researchers |
Q90521116 | Real-Life Patterns of Exacerbations While on Inhaled Corticosteroids and Long-Acting Beta Agonists for Asthma over 15 Years |
Q90567938 | Relationship of Initial Pancreatic Enzyme Replacement Therapy Dose With Weight Gain in Infants With Cystic Fibrosis |
Q58695012 | Retrospective cohort study comparing the risk of severe hepatotoxicity in hospitalized patients treated with echinocandins for invasive candidiasis in the presence of confounding by indication |
Q57470112 | Risks of Benzodiazepines in Chronic Obstructive Pulmonary Disease with Comorbid Posttraumatic Stress Disorder |
Q34156032 | The association of episiotomy with obstetric anal sphincter injury--a population based matched cohort study |
Q34476667 | The association of statin use with reduced incidence of venous thromboembolism: a population-based cohort study |
Q37731789 | The challenges of comparing results between placebo controlled randomized trials and non-experimental new user, active comparator cohort studies: the example of olmesartan |
Q39213494 | The use of epidural analgesia for intrapartum pain relief in publicly funded healthcare |
Q64134862 | Twenty-year trend in mortality among hospitalized patients with pneumococcal community-acquired pneumonia |
Search more.